Evidence map›Paper›PMID 23474464›Full record

ReviewPlasmid2013

Plasmid R6K replication control.

Sheryl A Rakowski, Marcin Filutowicz

Open access · greenAbstract readReview
In one paragraph

Review in Plasmid, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Reconstituting alternative life using the test-bed of cell-free systems.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  5. Shewanella oneidensis: Biotechnological Application of Metal-Reducing Bacteria.Advances in biochemical engineering/biotechnology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. What remains from living cells in bacterial lysate-based cell-free systems.Computational and structural biotechnology journal · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Golden Gate Assembly of Aerobic and Anaerobic Microbial Bioreporters.Applied and environmental microbiology · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. ISFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sheryl A RakowskiDepartment of Bacteriology, University of Wisconsin, Madison, WI, USA.
Marcin Filutowicz
University of Wisconsin–Madison · US

Funding

Delivering drugs via bacterial secretion systemsR21AI081087 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI FILUTOWICZ, MARCIN S · 2009 to 2010
$365k
NIAID NIH HHS AI081087NIAID NIH HHS R21 AI081087
6 · The paper itself

Abstract

The focus of this minireview is the replication control of the 39.9-kb plasmid R6K and its derivatives. Historically, this plasmid was thought to have a narrow host range but more recent findings indicate that its derivatives can replicate in a variety of enteric and non-enteric bacterial species (Wild et al., 2004). In the four-plus decades since it was first described, R6K has proven to be an excellent model for studies of plasmid DNA replication. In part this is because of its similarities to other systems in which replication is activated and regulated by Rep protein and iteron-containing DNA. However its apparent idiosynchracies have also added to its significance (e.g., independent and co-dependent replication origins, and Rep dimers that stably bind iterons). Here, we survey the current state of knowledge regarding R6K replication and place individual regulatory elements into a proposed homeostatic model with implications for the biological significance of R6K and its multiple origins of replication.

Indexed as

DNA ReplicationBinding SitesDNA, BacterialDNA HelicasesEscherichia coliHomeostasisModels, MolecularPlasmidsProtein MultimerizationRegulatory Sequences, Nucleic AcidReplication OriginTandem Repeat SequencesTrans-ActivatorsDNA, BacterialDNA Helicasesreplication initiator proteinTrans-Activators

Identifiers

PMID23474464
PMCPMC3691012
OpenAlexW1997138603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.